drugset / Trial / NCT00095147

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00095147

Phase 3 Completed 431 enrolled Bristol-Myers Squibb
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical research study is to learn if Abatacept or Infliximab in combination with Methotrexate demonstrate a greater reduction in disease activity over placebo.

Timeline

Start
2005-02
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Abatacept Other / unclassified 10 mg/kg Intravenous
Comparator Infliximab Monoclonal antibody 3 mg/kg Intravenous
Comparator Methotrexate Small molecule

Indications